PharmaCorp Rx Inc.
PCRX.V
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -54.64% | 23.92% | 951.29% | -10.71% | -9.30% |
Total Receivables | 37.72% | 225.89% | -- | -- | -- |
Inventory | 274.32% | 518.78% | -- | -- | -- |
Prepaid Expenses | -29.98% | 209.74% | 2,100.00% | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -2.35% | -- |
Total Current Assets | -49.86% | 25.96% | 918.65% | -10.39% | -6.11% |
|
|||||
Total Current Assets | -49.86% | 25.96% | 918.65% | -10.39% | -6.11% |
Net Property, Plant & Equipment | 315.45% | 15.87% | -- | -- | -- |
Long-term Investments | 457.18% | 210.86% | -- | -- | -- |
Goodwill | 457.18% | 210.86% | -- | -- | -- |
Total Other Intangibles | 148.16% | 124.97% | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 3.05% | 34.00% | 1,025.40% | -10.39% | -6.11% |
|
|||||
Total Accounts Payable | 193.08% | 24.08% | 558.30% | 27.43% | 14.75% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -5.46% | 13.31% | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 148.64% | 19.33% | 790.81% | 27.43% | 14.75% |
|
|||||
Total Current Liabilities | 148.64% | 19.33% | 790.81% | 27.43% | 14.75% |
Long-Term Debt | -11.34% | -4.04% | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -9.64% | 24.34% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 281.19% | 47.27% | -- | -- | -- |
Total Liabilities | 116.90% | 21.64% | 2,642.15% | 27.43% | 14.75% |
|
|||||
Common Stock & APIC | -6.78% | 36.29% | 629.33% | -2.47% | 2.43% |
Retained Earnings | 31.70% | -55.78% | -47.41% | -17.02% | -30.21% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -4.45% | 34.71% | 970.84% | -11.16% | -6.46% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -4.45% | 34.71% | 970.84% | -11.16% | -6.46% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -17.28% | 64.38% | -- | -- | -- |
Total Equity | -4.56% | 34.92% | 978.27% | -11.16% | -6.46% |
|